Trinity College Dublin (TCD), in Ireland, is to be the recipient of a new specialist 3D bioprinting facility supported by a collaboration between multinational medical device and pharmaceutical company Johnson & Johnson, and the AMBER research center.

With preparations beginning in the first quarter of this year, the new 3D bioprinting laboratory is due to be opened by the close of 2018.

Professor Michael Morris, AMBER director, comments.